<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04167631</url>
  </required_header>
  <id_info>
    <org_study_id>MANS.VI-RADS</org_study_id>
    <nct_id>NCT04167631</nct_id>
  </id_info>
  <brief_title>Can VI-RADS/ADC Accurately Stage Bladder Cancer??</brief_title>
  <official_title>Can Vesical Imaging-Reporting And Data System and Apparent Diffusion Coefficient Values (the VI-RADS/ADC) Accurately Predict Non-Muscle Invasive Bladder Cancer</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mansoura University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mansoura University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Vesical Imaging-Reporting And Data System (VI-RADS) is proposed for predicting muscle
      invasive bladder cancer (MIBC) using multi-parametric MRI. However, No validation study on
      VI-RADS has been reported yet. Apparent diffusion coefficient (ADC) values on
      diffusion-weighted MRI are reportedly significantly lower in MIBC than those in
      non-MIBC(NMIBC).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Vesical Imaging-Reporting And Data System (VI-RADS) is proposed for predicting muscle
      invasive bladder cancer (MIBC) using multi-parametric MRI. However, No validation study on
      VI-RADS has been reported yet. Apparent diffusion coefficient (ADC) values on
      diffusion-weighted MRI are reportedly significantly lower in MIBC than those in
      non-MIBC(NMIBC).

      We aim to examine the accuracy of VI-RADS for predicting MIBC in final histopathology
      specimen. To assess whether incorporating ADC into VI-RADS improves the MIBC predictive
      accuracy of VI-RADS
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">January 1, 2019</start_date>
  <completion_date type="Anticipated">June 1, 2020</completion_date>
  <primary_completion_date type="Anticipated">June 1, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Vesical Imaging-Reporting And Data System (VI-RADS) for discriminating muscle invasive bladder cancer (MIBC) from non-muscle invasive bladder cancer (NMIBC) using multi-parametric MRI.</measure>
    <time_frame>18 months</time_frame>
    <description>assessed by final histopathology specimen retrieved by enbloc transurethral resection of bladder tumors (ERBT)</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">150</enrollment>
  <condition>MRI Contrast Media Adverse Reaction</condition>
  <condition>Bladder Cancer</condition>
  <condition>Bladder Disease</condition>
  <condition>Bladder Neoplasm</condition>
  <condition>Bladder Urothelial Carcinoma</condition>
  <condition>Bladder Cancer Stage</condition>
  <condition>Diagnoses Disease</condition>
  <arm_group>
    <arm_group_label>Multiparametric MRI</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Vesical Imaging-Reporting And Data System (VI-RADS) using multi-parametric MRI.</description>
  </arm_group>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>Multi-parametric MRI</intervention_name>
    <description>Vesical Imaging-Reporting And Data System (VI-RADS) for predicting non-muscle invasive bladder cancer (NMIBC) using multi-parametric MRI.</description>
    <arm_group_label>Multiparametric MRI</arm_group_label>
    <other_name>MP-MRI</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients diagnosed at the out-patient cystoscopy with papillary or small nodular
             bladder tumour

        Exclusion Criteria:

          -  fungating lesions

          -  beyond the scope of enbloc resection
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ahmed Mosbah, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Mansoura University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mohammed Aboelghar, MD</last_name>
    <role>Study Director</role>
    <affiliation>Mansoura University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Urology and Nephrology Center</name>
      <address>
        <city>Mansoura</city>
        <state>Aldakahlia</state>
        <zip>35516</zip>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>November 2019</verification_date>
  <study_first_submitted>November 15, 2019</study_first_submitted>
  <study_first_submitted_qc>November 15, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">November 19, 2019</study_first_posted>
  <last_update_submitted>November 20, 2019</last_update_submitted>
  <last_update_submitted_qc>November 20, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">November 22, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mansoura University</investigator_affiliation>
    <investigator_full_name>Mahmoud Laymon</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>VI-RADS</keyword>
  <keyword>Multiparametric MRI</keyword>
  <keyword>Non-muscle invasive bladder cancer (NMIBC)</keyword>
  <keyword>Muscle invasive bladder cancer (MIBC)</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Urinary Bladder Neoplasms</mesh_term>
    <mesh_term>Carcinoma, Transitional Cell</mesh_term>
    <mesh_term>Urinary Bladder Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

